Pfizer is providing an excellent example on how not to deal with product problems and recalls . While the drug industry has some unique attributes, there are several learnings that are applicable to other sectors as well. I have written extensively on Pfizer's mishandling of the recall of Bextra , it seems that Pfizer has another situation to deal with - a somewhat likely recall of another blockbuster drug Viagra. Based on the data presented so far, I think that the number of people affected is still small (unless others have not yet come forward). However, it is interesting to watch since that is how most drug problems come to light. If we go back and look at the recent recalls of other drugs, for instance Tysabri, Adderall XR (in Canada), Vioxx and Bextra, the first reports were generally of isolated cases. Thus, I do not expect a recall of Viagra right away but this could be the first step in the process. How has Pfizer responded to Viagra controversy so far? Let us review the t...
Tips from a freelancer consultant for the benefit of other gig economy and self-employed workers and contractors.